Treatment Advances for Canine Mast Cell Tumors is a free veterinary CE offering made possible through the generous educational support of QBiotics®.
This course utilizes the archive of a live presentation.
The diagnosis and treatment of canine mast cell tumors requires an awareness of the latest advancements. Dr. Sue Ettinger outlines the use of cytological grading and lymph node aspiration in the diagnosis process. To aid clinicians in providing effective treatment, the doctor will share her in-the-trenches experience with STELFONTA® (tigilanol tiglate injection). She will outline her tips regarding what makes a dog a suitable candidate and, just as importantly, what does not. Dr. Ettinger includes cases from her patients including tumor destruction and wound healing. Via this presentation, clinicians can gain confidence including STELFONTA® in their treatment toolbox.
Upon completion of this course, the participant should be able to discuss latest advances in canine mast cell tumor diagnosis. In addition, the participant should be able to discuss the appropriate use of STELFONTA® (tigilanol tiglate injection), including tumor, patient, and client considerations. This also includes factors critical to treatment success.